我国某省原研药与仿制药价格差异与市场份额实证研究

Empirical research of price difference and market share between brand-name drugs and generics in one province in China

目的:为完善国家原研药与仿制药管理工作提供科学参考。方法:根据某省药品招标采购中心数据库的数据,分析该省原研药与仿制药的价格差异与市场份额。结果:该省198个样本药品中,原研药与仿制药的价格差异倍数的均值为3.6倍,高于《药品政府定价办法》规定的差价率。结论:我国原研药与仿制药的价格差异高于国家规定。

Objective：To provide scientific reference for the country＇s price management of brand-name drugs and generics.Methods：We analyzed price comparison and market share between brand-name drugs and generics in a province with the data from the database of medicine bidding and purchase center in the province.Results：The average price ratio of the 198 samples between brand-name drugs and generics was 3.6 in the province.This was higher than the price difference rate as required by the Governmental Pricing Method for the Pharmaceuticals in China.Conclusion：The price difference between brand-name drugs and generics is bigger than the one the government required.